Cargando…
Blocking EZH2 methylation transferase activity by GSK126 decreases stem cell-like myeloma cells
EZH2 is a critical epigenetic regulator that is deregulated in various types of cancers including multiple myeloma (MM). In the present study, we hypothesized that targeting EZH2 might induce apoptosis in myeloma cells including stem cell-like cells (CSCs). We investigated the effect of EZH2 inhibit...
Autores principales: | Zeng, Delong, Liu, Maoxing, Pan, Jingxuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5356890/ https://www.ncbi.nlm.nih.gov/pubmed/27926488 http://dx.doi.org/10.18632/oncotarget.13773 |
Ejemplares similares
-
Pharmacological inhibition of EZH2 by GSK126 decreases atherosclerosis by modulating foam cell formation and monocyte adhesion in apolipoprotein E-deficient mice
por: Wei, Xianjing, et al.
Publicado: (2021) -
Diosgenin and GSK126 Produce Synergistic Effects on Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Mediating EZH2 via the Rho/ROCK Signaling Pathway
por: Liu, Shanshan, et al.
Publicado: (2020) -
Combination Treatment with GSK126 and Pomalidomide Induces B-Cell Differentiation in EZH2 Gain-of-Function Mutant Diffuse Large B-Cell Lymphoma
por: Park, Sungryul, et al.
Publicado: (2020) -
The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells
por: Yu, Tianfu, et al.
Publicado: (2017) -
Anthelmintic pyrvinium pamoate blocks Wnt/β-catenin and induces apoptosis in multiple myeloma cells
por: Xu, Fang, et al.
Publicado: (2020)